Home › Major Depressive Disorder › Ohio › Cincinnati
Major Depressive Disorder clinical trials in Cincinnati, OH
11 studies for Major Depressive Disorder are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
RecruitingPhase 3
- University of Cincinnati, Cincinnati
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
RecruitingPhase 3
- University of Cincinnati Medical Center, Cincinnati
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RecruitingPhase 3
- Patient Priority Clinical Sites LLC, Cincinnati
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecruitingPhase 3
- Vanda Investigational Site, Cincinnati
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecruitingPhase 3
- Patient Priority Clinical Sites LLC, Cincinnati
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Mason · 19 mi away
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
RecruitingPhase 1/2
- Lindner Center of Hope, Mason · 19 mi away
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RecruitingPhase 3
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
Recruiting
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 202, Cincinnati
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Cincinnati
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA30 studies
- Atlanta, GA24 studies
- Philadelphia, PA22 studies
- Orlando, FL19 studies
- Tampa, FL17 studies
- Miami, FL17 studies
- Chicago, IL16 studies
- San Diego, CA16 studies
- Houston, TX16 studies
- Little Rock, AR14 studies
- Orange, CA13 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Lung Cancer19 studies
- Obesity19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.